Seoul National University Hospital
Seoul, 03080, South Korea
NCT Number: NCT03605121
Metabolic syndrome including increased body mass index or waist circumference is known to be a risk factor of cardiovascular disease. However, the relationship between body mass index or waist circumference and clinical outcome after cardiac surgery has not been fully elucidated.
Looking for future studies?
Notify Me20 year and older
All sexes
Observational
Seoul, 03080, South Korea
Along with body mass index, which is determined with height and weight, waist circumference reflects abdominal obesity and may increase cardio-metabolic risk and all-cause morbidity/mortality. In this observational study, we will review the electronic medical records of patients underwent cardiac surgery and assess their waist circumference, measured on preoperative computed tomography, as well as body mass index. The relationship between body mass index or waist circumference and mortality after cardiac surgery will be analysed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The relationship between body mass index or waist circumference and clinical outcome in patients undergoing cardiac surgery will be assessed
Time frame: through study completion, average 3 years
mortality after cardiac surgery
Seoul National University Hospital
Other
Association Between Waist Circumference or BMI and Clinical Outcome in Cardiac Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05972109
Body Weight, Glucose Metabolism Disorders
San Francisco, California, United States
View Trial DetailsNCT03375788
Body Weight, Digestive System Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06057207
Adiponectin, Body Weight
Osijek, Croatia
View Trial DetailsNCT07125638
Bile Reflux Gastritis, Body Weight
Naples, naples, Italy
View Trial Details